Lupin Group’s Kyowa Sees Japan-India Collaboration as Key to Survival: Pres.

April 1, 2015
Kyowa President Ray Tsunoda Kyowa Pharmaceutical Industry, a wholly owned subsidiary of Indian generic major Lupin Ltd., is to weather fierce competition in the Japanese generic market by closely collaborating with its parent, President Ray Tsunoda says. “The collaboration between...read more